Current research status and clinical applications of noninvasive preimplantation genetic testing: A review
- PMID: 39465745
- PMCID: PMC11460858
- DOI: 10.1097/MD.0000000000039964
Current research status and clinical applications of noninvasive preimplantation genetic testing: A review
Abstract
Noninvasive preimplantation genetic testing (ni-PGT) is conducted by obtaining genetic information from embryos through the analysis of free DNA released by embryos in spent embryo culture medium or blastocoel fluid. Compared to conventional preimplantation genetic testing relying on trophectoderm biopsy, ni-PGT is characterized by its noninvasiveness. It has demonstrated early advancements in the detection of embryonic chromosomal aneuploidies and the diagnosis of monogenic diseases, showcasing considerable potential for clinical application. However, there are substantial controversies in the literature concerning the reliability of ni-PGT, the source of cell-free DNA, and maternal contamination. This paper elaborates on the principles, research advancements, effectiveness, and limitations of ni-PGT to provide a basis for clinical applications.
Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
References
-
- Ely DM, Driscoll AK. Infant mortality in the United States, 2019: data from the period linked birth/infant death file. Natl Vital Stat Rep. 2021;70:1–18. - PubMed
-
- Silver RM. Fetal death. Obstet Gynecol. 2007;109:153–67. - PubMed
-
- Rai R, Regan L. Recurrent miscarriage. Lancet. 2006;368:601–11. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
